In conclusion, the current study demonstrates that solid-organ transplantation and immunosuppressive medication post-transplantation are associated with changes in osteocytic protein expression, including increased FGF23 and sclerostin expression, that appear to be distinguishable from the effects of CKD alone on altered osteocyte biology. The gene discussed is SOST; the disease is chronic kidney disease.